• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Fibrogen Inc CS (NQ: FGEN )

    1.281 +0.031 (+2.50%)
    Streaming Delayed Price Updated: 2:42 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,009,091
    Open 1.260
    Bid (Size) 1.280 (15)
    Ask (Size) 1.290 (14)
    Prev. Close 1.250
    Today's Range 1.220 - 1.340
    52wk Range 0.3333 - 2.930
    Shares Outstanding 98,210,168
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    What's Going On With FibroGen Stock Tuesday?
    FibroGen Inc (NASDAQ:FGEN) shares are trading higher Tuesday morning after the company said the FDA cleared its Investigational New Drug (IND) of FG-3165. FibroGen also announced a new clinical trial... 
    Via Benzinga
    Exposures Product Safety

    Performance

    YTD
    +54.26%
    +54.26%
    1 Month
    +6.78%
    +6.78%
    3 Month
    +30.17%
    +30.17%
    6 Month
    +32.05%
    +32.05%
    1 Year
    -34.96%
    -34.96%

    More News

    Read More
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Recap: FibroGen Q4 Earnings
    Via Benzinga
    FibroGen Stock Is Surging After The Bell: What's Going On?
    Via Benzinga
    Exposures Product Safety
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    7 Penny Biotech Stocks to Triple Your Investment
    Via InvestorPlace
    Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
    Via AB Newswire
    FibroGen Shares Climb On Strong Q1 Sales
    Via Benzinga
    Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why Zeta Global Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Exposures Glyphosate
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape
    Via Benzinga
    3 Nightmare Nasdaq Stocks Not Worth Holding Another Day
    Via InvestorPlace
    Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412 Million Deal
    Via Talk Markets
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Earnings Scheduled For February 26, 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.